Human IFN-Omega
Catalog Number: 11395
Human IFN-Omega inhibits the proliferation of a variety of tumor cell lines in vitro, stimulates natural killer cell activity, and enhances the expression of major histocompatibility complex class I antigens.
$405.00
Specifications
Formulation | Supplied frozen with a carrier protein |
---|---|
Molecular Weight | 20 kDa |
Source | Recombinant Hu-IFN-ω expressed in E.coli |
Purity | > 95% by SDS-PAGE stained by Coomassie Blue Endotoxin level < 1 EU/μg |
Bioactivity | Measured using a cytopathic inhibition assay on human lung carcinoma cell line A549 with encephalomyocarditis virus (EMCV) |
Storage | For retention of full activity store at -70°C or below and avoid repeated freeze/thaw cycles |
Synonyms | IFN-ω |
Accession Number | X58822 |
Citations
4 Citations:
- Richez, Christophe, et al. (2009). TLR4 Ligands Induce IFN-alpha Production by Mouse Conventional Dendritic Cells and Human Monocytes after IFN-beta Priming. Journal of Immunology, 10 pgs. PMID: 19124725. (link)
- Kang, Dong-Chul, et al. (2004). Expression Analysis and Genomic Characterization of Human Melanoma Differentiation Associated Gene-5, mda-5: a Novel Type I Interferon-Responsive Apoptosis-Inducing Gene. Oncogene, 12 pgs. PMID: 14676839. (link)
- Qu, C, et al. (2003). Autocrine type I IFN and contact with endothelium promote the presentation of influenza A virus by monocyte-derived APC. Journal of Immunology, 10 pgs. PMID: 12517968. (link)
- Adolf, Gunther (1990). Monoclonal antibodies and enzyme immunoassays specific for human interferon (IFN) omega 1: evidence that IFN-omega 1 is a component of human leukocyte IFN. Virology, 8 pgs. PMID: 1691561. (link)